IL-22, GM-CSF and IL-17 in Peripheral CD4+ T Cell Subpopulations During Multiple Sclerosis Relapses and Remission. Impact of Corticosteroid Therapy

PLoS ONE - United States
doi 10.1371/journal.pone.0173780
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Prophylactic Treatment Against GM-CSF, but Not IL-17, Abolishes Relapses in a Chronic Murine Model of Multiple Sclerosis

European Journal of Immunology
AllergyImmunology
2018English

Distinct, Specific IL-17- And IL-22-Producing CD4+ T Cell Subsets Contribute to the Human Anti-Mycobacterial Immune Response

Journal of Immunology
AllergyImmunology
2008English

IL-17 and IL-22 in Immunity: Driving Protection and Pathology

European Journal of Immunology
AllergyImmunology
2017English

Different IL-17-secreting TLR+ T Cell Subsets Are Associated With Disease Activity in Multiple Sclerosis

Immunology
AllergyImmunology
2017English

Disrupting the IL-36 and IL-23/IL-17 Loop Underlies the Efficacy of Calcipotriol and Corticosteroid Therapy for Psoriasis

JCI insight
Medicine
2019English

mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production

Journal of Immunology
AllergyImmunology
2016English

Effect of Interleukin (IL)-35 on IL-17 Expression and Production by Human CD4+ T Cells

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2017English

Chromatin Remodeling of Interleukin-17 (IL-17)-IL-17F Cytokine Gene Locus During Inflammatory Helper T Cell Differentiation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

IL-27 Regulates IL-10 and IL-17 From CD4+ Cells in Nonhealing Leishmania Major Infection

Journal of Immunology
AllergyImmunology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy